Study of Age, Body Mass Index, Stages of Colon Cancer Development, and Type of Treatment on Meprin Alpha Levels Among Colon Cancer Patients
DOI:
https://doi.org/10.54153/sjpas.2021.v3i4.305Keywords:
Meprin Alpha, Stage, Treatment, BMI, Colon cancerAbstract
Colon cancer is a disease that is characterized by the development of malignant cells in the epithelium or lining of the distal part of the colon. This study includes study of age, body mass index, stages of colon cancer development, and quality of treatment on meprin α (MEPA) levels among colon cancer patients as compared with the control group. This study has been conducted on (134) sample with ages ranging from (25-76) years: (74) of them are colon cancer patients from the patients treated in Mosul oncology and nuclear medicine hospital and Ibn-Sina teaching hospital/ Mosul and (60) samples as control group in Mosul city for the period from January to July 2020. The results showed that the normal mean of MEPA is (82.12± 3.65 ng / mL) in control group for both gender. While the activity of MEPA for colon cancer patients were (106.72±4.52 ng / mL), the level of enzyme was also affected by age and gender, whereas it increases with age in both the control group and colon cancer patients, its activity in males is higher than in females in control group only, and the effect of body mass index is observed in both the control group and the patients. The results also showed a significant increase in the activity of MEPA in colon cancer patients as compared with the control group, while there was a significant increase in colon cancer patients in stages II, III and IV compared with patients in the first stage. The effect of the type of treatment, as it has been found that the activity of enzyme was significantly lower for MEPA in the group of patients undergoing surgical removal of colon tumors and patients treated with chemotherapy as compared without treatment patients (Newly diagnosed). It was noted that MEPA is affected by various factors such as gender, age, BMI, as well as the development of colon cancer and the type of treatment used.
The results showed that the normal mean of MEPA is (82.12± 3.65 ng / mL) in control group for both sexes. While the activity of MEPA for colon cancer patients were (106.72±4.52 ng / mL), the level of enzyme was also affected by age and sex, whereas it increases with age in both the control group and colon cancer patients, its activity in males is higher than in females in control group only, and the effect of body mass index is observed in both the control group and the patients.
The results also showed a significant increase in the activity of MEPA in colon cancer patients as compared with the control group, while there was a significant increase in colon cancer patients in stages II, III and IV compared with patients in the first stage
The effect of the type of treatment, as it has been found that the activity of enzyme was significantly lower for MEPA in the group of patients undergoing surgical removal of colon tumors and patients treated with chemotherapy as compared without treatment patients.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Samarra Journal of Pure and Applied Science
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright Notice
Authors retain copyright and grant the SJPAS journal right of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in Samarra Journal of Pure and Applied Science.
The Samarra Journal of Pure and Applied Science permits and encourages authors to archive Pre-print and Post-print items submitted to the journal on personal websites or institutional repositories per the author's choice while providing bibliographic details that credit their submission, and publication in this journal. This includes the archiving of a submitted version, an accepted version, or a published version without any Risks.
